Jnj marketwatch.

Johnson & Johnson company facts, information and financial ratios from MarketWatch.

Jnj marketwatch. Things To Know About Jnj marketwatch.

Discover historical prices for JNJ stock on Yahoo Finance. View daily, weekly or monthly format back to when Johnson & Johnson stock was issued.Oct 30, 2023 · Johnson & Johnson closed $34.01 below its 52-week high ($181.04), which the company achieved on December 14th. The stock underperformed when compared to some of its competitors Monday, as Procter ... NVIDIA Corporation Common Stock. $458.09 +9.39 +2.09%. CGC. Canopy Growth Corporation Common Shares. $1.275 -0.065 -4.85%. Johnson & Johnson Common …Johnson & Johnson SEC filings breakout by MarketWatch. View the JNJ U.S. Securities and Exchange Commission reporting information.View Johnson & Johnson JNJ investment & stock information. Get the latest Johnson & Johnson JNJ detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Founded in 1886, Johnson & Johnson (JNJ 1.11%) ... Today, with the stock price trading at around $170, the investment would now be worth more than $84,000, for a return of 237%. Over a 20-year ...Dec 1, 2023 · The 71 analysts offering price forecasts for Johnson & Johnson have a median target of 184.06, with a high estimate of 215.00 and a low estimate of 40.00. The median estimate represents a 86.05 ...

Johnson & Johnson company facts, information and financial ratios from MarketWatch.

Johnson & Johnson JNJ, -0.53% said Monday that 802.7 million shares of its common stock were validly tendered and not validly withdrawn in a Kenvue Inc. KVUE, +2.35% tender offer that expired at ...Johnson & Johnson company facts, information and financial ratios from MarketWatch.Johnson & Johnson company facts, information and financial ratios from MarketWatch.JNJ - Johnson & Johnson Advanced Chart, Quote and financial news from the leading provider and award-winning BigCharts.com.

Find the latest Johnson & Johnson (JNJ) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Johnson & Johnson (JNJ) NYSE - NYSE Delayed ...

Johnson & Johnson company facts, information and financial ratios from MarketWatch.

4 days ago - Market Watch. Johnson & Johnson MedTech Acquires Laminar, Inc. NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson MedTech1 today announced ...Johnson & Johnson company facts, information and financial ratios from MarketWatch.Johnson & Johnson company facts, information and financial ratios from MarketWatch.Johnson & Johnson Stock Earnings. The value each JNJ share was expected to gain vs. the value that each JNJ share actually gained. JNJ ( JNJ) reported Q3 2023 earnings per share (EPS) of $1.98, missing estimates of $2.52 by 21.38%. In the same quarter last year, JNJ 's earnings per share (EPS) was $1.68. JNJ is expected to release next earnings ...JNJ - Johnson & Johnson Historical Chart, Quote and financial news from the leading provider and award-winning BigCharts.com.JNJ | Complete Johnson & Johnson stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Johnson & Johnson company facts, information and financial ratios from MarketWatch.

Johnson & Johnson company facts, information and financial ratios from MarketWatch.Johnson & Johnson company facts, information and financial ratios from MarketWatch.Overall, Johnson & Johnson earned an adjusted $2.68 per share on $24.75 billion in first-quarter sales. Earnings climbed a fraction while sales rose 5.6%. Both measures beat JNJ stock analysts ...Johnson & Johnson company facts, information and financial ratios from MarketWatch.4 Mei 2023 ... Johnson & Johnson (JNJ) ... A long-time financial journalist, Dan is a veteran of SmartMoney, MarketWatch, CBS MoneyWatch, InvestorPlace and ...The 71 analysts offering price forecasts for Johnson & Johnson have a median target of 184.06, with a high estimate of 215.00 and a low estimate of 40.00. The median estimate represents a 86.05 ...

Johnson & Johnson company facts, information and financial ratios from MarketWatch.Johnson & Johnson company facts, information and financial ratios from MarketWatch.

Johnson & Johnson company facts, information and financial ratios from MarketWatch.The latest price target for . Johnson & Johnson (NYSE: JNJ) was reported by Cantor Fitzgerald on November 20, 2023.The analyst firm set a price target for $215.00 expecting JNJ to rise to within ... Get the latest Johnson & Johnson (JNJ) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.NewsNow aims to be the world's most accurate and comprehensive aggregator of Johnson & Johnson news, covering the latest share price, vaccine news and more from the best online news publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication. NewsNow Classifieds.Johnson & Johnson company facts, information and financial ratios from MarketWatch.Johnson & Johnson company facts, information and financial ratios from MarketWatch.Complete Johnson & Johnson stock information by Barron's. View real-time JNJ stock price and news, along with industry-best analysis.

Johnson & Johnson SEC filings breakout by MarketWatch. View the JNJ U.S. Securities and Exchange Commission reporting information.

31 Okt 2023 ... Shares of Johnson & Johnson JNJ inched 0.89% higher to $148.34 Tuesday ... Subscribe to MarketWatch. Get this article and all of MarketWatch ...

Johnson & Johnson company facts, information and financial ratios from MarketWatch.Johnson & Johnson JNJ, -0.53% said Monday that 802.7 million shares of its common stock were validly tendered and not validly withdrawn in a Kenvue Inc. KVUE, +2.35% tender offer that expired at ...Johnson & Johnson (NYSE:JNJ) Stock Position Raised by Graham Capital Management L.P. marketbeat.com - November 30 at 12:42 PM Johnson & Johnson Buys Laminar For $400 Million, Trims Profit Outlook marketwatch.com - November 30 at 10:15 AMJohnson & Johnson JNJ, +0.32% said Thursday that its medical technology segment has acquired medical device maker Laminar Inc. in a deal that will reduce its full-year 2023 and 2024 earnings per ...Based on short-term price targets offered by 17 analysts, the average price target for Johnson & Johnson comes to $177.88. The forecasts range from a low of $155.00 to a high of $215.00. The ...Johnson & Johnson company facts, information and financial ratios from MarketWatch.Johnson & Johnson company facts, information and financial ratios from MarketWatch.Analyst Forecast. According to 15 analysts, the average rating for JNJ stock is "Buy." The 12-month stock price forecast is $168.0, which is an increase of 10.45% from the latest price.Johnson & Johnson company facts, information and financial ratios from MarketWatch.

Stock Market News - MarketWatch offers all the latest stock market news and currencies market news. ... JNJ 2.41%. Dec. 3, 2023 at 8:00 a.m. ET by Barron's.7 Nov 2023 ... Shares of Johnson & Johnson JNJ slumped 0.53% to $150.90 Tuesday, on ... Subscribe to MarketWatch. Get this article and all of MarketWatch ...Johnson & Johnson beats earnings estimates and downplays obesity drugs’ impact on its med-tech business MarketWatch. 06:39 AM ET. J&J’s stock rallies after profit and sales rise above expectations, full-year outlook increased MarketWatch. 06:25 AM ET. Johnson & Johnson stock climbs 1.7% premarket after Q3 results MarketWatch. 06:22 AM ETInstagram:https://instagram. ueda jackson holevixy tickervision plans for seniorstop crypto brokers Real time Johnson & Johnson (JNJ) stock price quote, stock graph, news & analysis. best monthly dividend etfs 2023computer stock Johnson & Johnson company facts, information and financial ratios from MarketWatch. e mini future Johnson & Johnson MedTech acquired Laminar for an upfront payment of $400 million, subject to customary adjustments, with additional potential clinical and …Johnson & Johnson company facts, information and financial ratios from MarketWatch.